CHFC-Wurzburg acquires MILabs' E-class SPECT/CT system to enhance heart failure research

The nuclear cardiology core facility of the CHFC-Würzburg has acquired MILabs E-class SPECT/CT system to enhance its existing top-level basic, translational and clinical research activities in the field of heart failure.

Upgradeable with simultaneous PET imaging, the E-Class SPECT/CT system combines economic use with exceptional translational imaging performance.

The system features list mode based simultaneous high-resolution multi-isotope gated cardiac imaging capabilities - a critical performance feature for gaining better insights into, e.g. cardiac neuronal and vascular biology.

With an estimated 3 million heart failure patients in Germany and over 30 million worldwide, the CHFC- Würzburg uses world-class multi-disciplinary research for the development of new therapeutic strategies, which intervene early in the healing and remodeling processes of the heart.

The use of high-end SPECT imaging fused with the anatomical structure of the heart obtained with low-dose CT is essential for translational cardiology imaging. For instance, one can uniquely visualize cardiac sympathetic nervous activity with this high-resolution nuclear imaging technique.”

Prof. Dr. Takahiro Higuchi, Head of Pre-Clinical Imaging

We are delighted to collaborate with Dr. T. Higuchi’s team to optimize the performance of our multimodality E-Class imaging system for cardiac applications.

Because of the high spatial and temporal resolution of our nuclear imaging technologies, the system allows both global as well as regional functional and dynamic kinetic analysis.

Once upgraded with PET, by eliminating positron range blurring, the system enables, for the first time, murine cardiac imaging with 82Rb, a popular PET tracer used in the clinic.”

Prof. F. Beekman, founder & CEO of MILabs B.V.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    MILabs. (2019, June 19). CHFC-Wurzburg acquires MILabs' E-class SPECT/CT system to enhance heart failure research. News-Medical. Retrieved on July 23, 2019 from https://www.news-medical.net/news/20190402/CHFC-Wurzburg-acquires-MILabs-E-class-SPECTCT-system-to-enhance-heart-failure-research.aspx.

  • MLA

    MILabs. "CHFC-Wurzburg acquires MILabs' E-class SPECT/CT system to enhance heart failure research". News-Medical. 23 July 2019. <https://www.news-medical.net/news/20190402/CHFC-Wurzburg-acquires-MILabs-E-class-SPECTCT-system-to-enhance-heart-failure-research.aspx>.

  • Chicago

    MILabs. "CHFC-Wurzburg acquires MILabs' E-class SPECT/CT system to enhance heart failure research". News-Medical. https://www.news-medical.net/news/20190402/CHFC-Wurzburg-acquires-MILabs-E-class-SPECTCT-system-to-enhance-heart-failure-research.aspx. (accessed July 23, 2019).

  • Harvard

    MILabs. 2019. CHFC-Wurzburg acquires MILabs' E-class SPECT/CT system to enhance heart failure research. News-Medical, viewed 23 July 2019, https://www.news-medical.net/news/20190402/CHFC-Wurzburg-acquires-MILabs-E-class-SPECTCT-system-to-enhance-heart-failure-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
MILabs installs pre-clinical Adaptive microCT scanner at Jagiellonian University in Poland